About Technology Issues FAQ

Links

The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial

The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.